Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.77 |
| ▸ | PLAU | P00749 | 2/20 | 0.77 |
| ▸ | MASP2 | O00187 | 1/20 | 0.77 |
| ▸ | THPO | P40225 | 1/20 | 0.77 |
| ▸ | PRSS1 | P07477 | 6/20 | 0.72 |
| ▸ | PRSS3 | P35030 | 5/20 | 0.72 |
| ▸ | F2 | P00734 | 4/20 | 0.72 |
| ▸ | APEX1 | P27695 | 1/20 | 0.72 |
| ▸ | F10 | P00742 | 2/20 | 0.71 |
| ▸ | F12 | P00748 | 1/20 | 0.71 |
| ▸ | F7 | P08709 | 1/20 | 0.71 |
| ▸ | F3 | P13726 | 1/20 | 0.71 |
| ▸ | PKM | P14618 | 1/20 | 0.71 |
| ▸ | ST14 | Q9Y5Y6 | 3/20 | 0.68 |
| ▸ | PRMT1 | Q99873 | 2/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.68 |
| ▸ | HPGD | P15428 | 2/20 | 0.68 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.68 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.68 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL30999366 | 0.96 | PRSS1 (0.78) | LMNAPLAUMASP2THPOPRSS1 | |
| Hydrochloric Acid SCHEMBL392375 | 0.96 | PRSS1 (0.78) | LMNAPLAUMASP2THPOPRSS1 | |
| SCHEMBL8973288 | 0.90 | WDR5 (0.80) | LMNAPLAUMASP2THPOPRSS1 | |
| SCHEMBL394218 | 0.90 | WDR5 (0.80) | LMNAPLAUMASP2THPOPRSS1 | |
| Hydrochloric Acid SCHEMBL29182280 | 0.87 | PRSS1 (0.67) | LMNAPLAUMASP2THPOPRSS1 | |
| SCHEMBL6588885 | 0.87 | LMNA (0.62) | LMNAPLAUMASP2THPOPRSS1 | |
| SCHEMBL563315 | 0.87 | LMNA (1.00) | LMNAPLAUMASP2THPOPRSS1 | |
| SCHEMBL150756 | 0.87 | PLAU (1.00) | LMNAPLAUMASP2THPOPRSS1 | |
| SCHEMBL23188213 | 0.85 | LMNA (0.59) | LMNAPLAUMASP2THPOPRSS1 | |
| SCHEMBL4629405 | 0.85 | LMNA (0.59) | LMNAPLAUMASP2THPOPRSS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 423 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119836101-A | Perovskite solar cell based on diamine molten salt surface modification and preparation method thereof | 东方电气长三角(杭州)创新研究院有限公司 | 2025-04-15 | — | — | CN | claimed |
| CN-118513038-A | Hydrofining catalyst and preparation method and application thereof | 中国石油化工股份有限公司 | 2024-08-20 | — | — | CN | claimed |
| EP-2796112-B2 | Degradable implantable medical devices | ELIXIR MEDICAL CORP (US) | 2023-08-09 | — | — | EP | claimed |
| CN-115382576-B | Covalent organic framework-bismuth tungstate photocatalytic composite material and preparation method thereof | 黄石瀚海新材料科技有限公司 | 2023-05-16 | — | — | CN | claimed |
| CN-115382576-A | Covalent organic framework-bismuth tungstate photocatalytic composite material and preparation method thereof | 黄石瀚海新材料科技有限公司 | 2022-11-25 | — | — | CN | claimed |
| CN-115397109-A | Nano graphite carbon pore process pore-finishing agent and preparation method thereof | 广东利尔化学有限公司 | 2022-11-25 | — | — | CN | claimed |
| WO-2022217521-A1 | COVALENT BOND-LINKED TIO2@CTF‑PY HETEROJUNCTION MATERIAL, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | 苏州大学 | 2022-10-20 | — | — | WO | claimed |
| CN-112321782-B | Crystalline covalent triazine organic framework material and preparation method and application thereof | 华中科技大学 | 2021-12-03 | — | — | CN | claimed |
| CN-112321782-A | Crystalline covalent triazine organic framework material and preparation method and application thereof | 华中科技大学 | 2021-02-05 | — | — | CN | claimed |
| CN-108889334-B | Application of triazine covalent organic framework material containing hetero atoms in photocatalysis | 华中科技大学 | 2020-01-03 | — | — | CN | claimed |
| EP-2061629-A2 | METHOD OF DOPING SURFACES | Enbio Limited (IE) | 2009-05-27 | — | — | EP | claimed |
| US-20080274671-A1 | METHOD OF DOPING SURFACES | ENBIO LIMITED (IE) | 2008-11-06 | — | — | US | claimed |
| WO-2008033867-A2 | METHOD OF DOPING SURFACES | ENBIO LIMITED (IE) | 2008-03-20 | — | — | WO | claimed |
| EP-1549247-A4 | DRUG RELEASE FROM ANTITHROMBOGENIC MULTI-LAYER COATED STENT | MEDIPLEX CORP (KR) | 2007-10-31 | — | — | EP | claimed |
| EP-1549247-A1 | DRUG RELEASE FROM ANTITHROMBOGENIC MULTI-LAYER COATED STENT | Mediplex Corporation (KR) | 2005-07-06 | — | — | EP | claimed |
| WO-2004028406-A1 | DRUG RELEASE FROM ANTITHROMBOGENIC MULTI-LAYER COATED STENT | MEDIPLEX CORPORATION (KR) | 2004-04-08 | — | — | WO | claimed |
| US-6702850-B1 | Multi-coated drug-eluting stent for antithrombosis and antirestenosis | MEDIPLEX CORPORATION KOREA (KR) | 2004-03-09 | — | — | US | claimed |
| US-6106866-A | ANTITUMOR AGENTS AND DERMATAN SULFATE | ACCESS PHARMACEUTICALS, INC. (US) | 2000-08-22 | — | — | US | claimed |
| EP-0794796-A1 | COMPLEXES OF DERMATAN SULFATE AND DRUGS, GIVING IMPROVED PHARMACOKINETICS | Access Pharmaceuticals, Inc. (US) | 1997-09-17 | — | — | EP | claimed |
| WO-1996019242-A1 | COMPLEXES OF DERMATAN SULFATE AND DRUGS, GIVING IMPROVED PHARMACOKINETICS | ACCESS PHARMACEUTICALS, INC. (US) | 1996-06-27 | — | — | WO | claimed |